Description
The recombinant antibody is capable of very effectively inhibiting the growth of tumor cells A431 and HUVEC and has a very remarkable inhibition effect, and the inhibition rate of the recombinant antibody tothe tumor cell HUVEC is nearly 4 times of that of Avastin.
Target
Tumor
Isotype/Mimetic
Human IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression